purified using acid decaseination, ion-exchange chromatography and gel filtration. The results indicate that the factor is chemically and functionally similar to a growth factor which has been isolated from human platelets (Heldin et al., 1981a; Deuel et al., 1981; Raines & Ross, 1982) .
Materials and methods

Materials
Culture medium, antibiotics, trypsin and newborn calf serum were from Flow Laboratories. Na I25I and [3H]thymidine were from Amersham International. EGF was prepared from male mouse submaxillary gland by the method of Savage & Cohen (1972) and labelled by using lactoperoxidase (Thorell & Johansson, 1971) as previously described (Brown & Blakeley, 1983b) . Platelet-poor plasma (goat) was prepared by the method of 10% (v/v) newborn calf serum and antibiotics as described previously (Brown & Blakeley, 1983a,b) .
Partialpurification ofthe colostric basic growthfactor
General. All operations were carried out at 4°C except where otherwise stated. Protein determinations were made with the Bradford (1976) procedure with pig gamma globulin as standards.
Decaseination ofgoat's colostrum. Colostrum was obtained from a goat (number 565) within 1 h after parturition and frozen at -20°C until further processing. After thawing, 750ml of colostrum was centrifuged at 22000gav. for 30min and the aqueous phase was withdrawn from below the floating lipid. The pH of the defatted colostrumn was lowered to 4.4 by the dropwise addition of 1 Macetic acid. The acidified colostrum was stirred for 2 h and then left overnight without further stirring. The precipitated casein was removed by centrifugation as described above to yield decaseinated whey.
Cation-exchange chromatography. The decaseinated whey was dialysed (Spectrapor 3 dialysis tubing, Mr cut-off 3500) against 15 litres of 0.02M-ammonium formate (pH7.0) for approx. 60h followed by dialysis against 15 litres of 0.02M-Hepes [4-(2-hydroxyethyl)-1-piperazine-ethanesulphonic acid] (pH7.0) for 48h. The precipitate which formed was removed by centrifugation as described above and the clarified whey was applied to a column (1Ocm x 5cm) of carboxymethylcellulose (Whatman CM52) equilibrated with 0.02M-Hepes (pH 7.0). After sample application, the column was washed with 460 ml of 0.02M-Hepes (pH 7.0) followed by 1500ml of 0.2M-Hepes (pH 7.0). Finally the column was eluted with 300ml of 0.2M-Hepes (pH7.0) containing 1 M-NaCl. Throughout these procedures the column was operated with a 40cm head of pressure and a flow rate of approx. 150ml/h. Bulk fractions with the volumes indicated in Fig. 1 were collected.
Gel filtration. The 1211-EGF-inhibiting fraction eluted from the CM52 column by 0.2M-Hepes containing 1 M-NaCl ( Fig. 1) was concentrated from 100 ml to 4.4 ml by pressure ultrafiltration (Amicon PM1O membrane). The retentate was applied to a column (90cm x 2.6 cm) of Ultrogel AcA 54 equilibrated and eluted with phosphate-buffered saline (pH7.4) containing 1M-NaCl. The flow rate was maintained at 20ml/h using a peristaltic pump. Fractions (lOml) were monitored manually with a Zeiss spectrophotometer at 280nm.
Assays. The ability of samples to inhibit cellular 1251-EGF binding and to stimulate DNA synthesis in quiescent cultures of Swiss mouse 3T3 cells was measured as described previously (Brown & Blakeley, 1983b) .
Results
Partial purification
A cationic growth factor in goat's colostrum was partially purified by a sequence of acid decaseination, cation-exchange chromatography, and gel filtration. The purification was monitored by using two different assays; stimulation of DNA synthesis in quiescent 3T3 cell cultures and inhibition of 125I-EGF binding to 3T3 cells. Based on the latter assay, an increase in specific activity of about 350-fold was achieved with an overall recovery of approx. 3% (Table 1) .
The I251-EGF-inhibiting growth factor is present exclusively in the aqueous, non-casein (i.e. whey) fraction of colostrum since none of the inhibitory activity was lost on removal of fat (results not shown) or on acid-precipitation of casein (Table 1 ). The defatted, decaseinated whey was dialysed against 0.02M-Hepes (pH7.0) and applied to a CM52 column equilibrated with 0.02M-Hepes (pH7.0). Most of the 125I-EGFinhibiting activity was retained by the column and was not eluted by 0.2M-Hepes but was desorbed by 0.2M-Hepes containing 1 M-NaCl. The 125I-EGFinhibiting activity in approx. 1 litre of whey was collected in a concentrated form in 100ml of eluate. This '25I-EGF-inhibiting fraction was a potent stimulator of DNA synthesis in quiescent 3T3 cells (Fig. 1) . The unretained material from the CM52 column and the material eluted with the first 500ml of 0.2M-Hepes also contained considerable cell growth-promoting activity ( Fig. 1) but these fractions had little activity in the 125I-EGF binding assay. This result suggests that other growth factors, in addition to the 1251-EGFinhibiting material, are present in the decaseinated colostric whey.
The 1251-EGF-inhibiting activity eluted from the CM52 column was concentrated by ultrafiltra- The column and column sample were prepared and the column was developed as described in the Materials and methods section. The indicated fractions were collected and tested for their ability to inhibit 125I-EGF binding to Swiss 3T3 cells. Cells, grown in 24-well cluster trays (Nunc), were rinsed with 1-2ml of binding medium {DME containing 0.1% crystalline bovine serum albumin, 0.1 M-KI and 50mM-Bes [NN-bis(2-hydroxyethyl)-2-aminoethanesulphonic acid] adjusted to pH7.0}. Binding medium (0.5 ml/well) containing '25I-EGF (1.3ng/ml; 42000c.p.m./ng) and samples of the column fractions (40p1/ml) was added to the cells. After a 90min incubation at 37°C, the cells were washed and cell-associated radioactivity was determined. Non-specific 125I-EGF binding, measured as cellassociated radioactivity in the presence of unlabelled EGF (2pg/ml), was less than 5% of the total under these conditions. The mean value (n = 2) for the percentage inhibition of ' 251-EGF binding relative to the binding to untreated, control cells is shown. The column fractions were also tested for their ability to stimulate DNA synthesis in quiescent cultures of Swiss 3T3 cells. Test fractions (I0Al/ml of medium) were added directly to the depleted growth medium of cells grown on 3cm plastic dishes (Nunc).
[3H]Thymidine (201l) was added to give a final concentration of 1 pCi/ml (1 x 10-6M). After incubation for 40h at 37°C, the medium was removed from the dishes and the cells were washed twice with cold phosphate-buffered saline (pH 7.4). The cells were extracted for 30min with 1-2ml of cold 5% (w/v) trichloroacetic acid, rinsed with ethanol, and air dried. The cells were dissolved in 1 ml of 0.1 M-NaOH and 0.5 ml of this solution was mixed with lOml of acidified scintillation fluid for counting of 3H. (Table 2 ). The activity of the factor is not affected by dissociating agents (6M-urea, 4M-guanidinium chloride) but activity is totally destroyed on reduction by 2-mercaptoethanol. The factor is stable to heat, with no loss of activity on heating to 100°C for 5 min ( platelets (Heldin et al., 198 1a; Deuel et al., 1981; Raines & Ross, 1982 (Fig. 3) .
Unfractionated colostric whey inhibits 1251-EGF binding to Swiss 3T3 cells by decreasing the apparent affinity of the cellular receptors for 1251-EGF (Brown & Blakeley, 1983b) . However, the colostrum-mediated inhibition of 1251-EGF binding, although rapid and apparently competitive, was shown to differ in several important characteristics from the inhibition of binding induced by native, unlabelled EGF. Thus the inhibitory effect of colostrum is markedly decreased when the assay temperature is shifted from 37°C to 4°C, whereas unlabelled EGF is an equally effective competitive inhibitor at both temperatures. Incubation of cells with EGF causes a reduction in cell-surface EGF receptors, whereas exposure to colostrum does not induce EGF receptor down-regulation (Brown & Blakeley, 1983b) . Identical results (not shown) have been obtained using the partially purified CBGF. These findings suggest that the CBGF does not bind directly to cellular EGF receptors but inhibits 1251-EGF binding by an indirect mechanism. This is supported by the observation (Fig. 3) Table 2 . Sensitivity of the colostric basic growth factor to inactivation by proteolytic enzymes, denaturing conditions and reduction Aliquots of CBGF (post-AcA 54 pool) were exposed to phosphate-buffered saline, pH 7.4, 6M-urea, 4M-guanidinium chloride, or 2% ,B-mercaptoethanol for 24h at 4°C, then dialysed (exclusion limit 3500Da) against phosphatebuffered saline. The samples were subsequently tested for their ability to inhibit I 25I-EGF binding to Swiss 3T3 cells and to stimulate DNA synthesis in quiescent Swiss 3T3 cells. For each assay the remaining activity is expressed as a percentage of the activity in the phosphate buffered saline-treated controls. In a separate experiment, a sample of the post-AcA 54 pool was heated to 100°C for 5min and tested in the assays. The remaining activity is expressed as a percentage of the activity in unheated controls. In a third experiment, aliquots of the post-AcA 54 pool were incubated for 4h at 37°C with a mixture of trypsin and a-chymotrypsin (each at a concentration of 0.5mg/ml), a mixture of heat-inactivated trypsin and a-chymotrypsin (each at 0.5 mg/ml), or phosphate-buffered saline without enzymes. At the end of the incubation, soya bean trypsin inhibitor (2mg/ml) was added and the remaining activity in the proteinase-treated samples was measured and is expressed as a percentage of the activity in the phosphate buffered saline-treated controls.
Activity remaining (%) Fig. 5 . Effect of CBGF on the proliferation rate of Swiss 3T3 cells in low-serum medium Cells were seeded at the indicated density (0, day 0) in DME containing 10% calf serum, incubated at 37°C for 24h and cell numbers (0) were determined as described below. The remaining dishes of cells were rinsed with serum-free DME and 2ml of this medium containing 0.2% calf serum without (@) or with (A) 7.5 ug of CBGF were added per dish. The medium with or without CBGF was changed at 3 day intervals (arrows). At the indicated times, cells were detached from the dishes by incubation (5 min at 37°C) with 2ml of Ca2+-and Mg2+-free phosphate-buffered saline which contained 0.43mM-EpTA and 0.05% trypsin. The cells were dispersed into a suspension of single cells by gentle pipetting and an aliquot of the cell suspension was diluted into Isoton and cells were counted using a Coulter Counter. Each point represents the mean value for cell number obtained from three dishes of cells. medium. It has been shown (Pledger et al., 1977 (Pledger et al., , 1978 Vogel et al., 1978) that low concentrations of PDGF induce 'competence' in treated cells but that additional growth factor(s), present in platelet-poor plasma, are necessary for 'progression' through the cell cyle. We have observed a similar effect using CBGF, which produced only a small stimulation of 3T3 cell DNA synthesis when added alone to serum-free medium (Fig. 4b) . However, the CBGF stimulated cells synergistically in combination with 5% (v/v) platelet-poor plasma (goat), which by itself had little stimulatory activity (Fig.  4b) . This result indicates that depleted medium contains residual 'progression' factors which allow the expression of the 'competence'-inducing activity of CBGF in the experiment shown in Fig. 4(a) .
The effect of CBGF on the proliferation rate of Swiss 3T3 cells is shown in Fig. 5 . Cells placed in low-serum medium (DME + 0.2% calf serum) showed an initial small increase in number but this was followed by a decrease in number. In contrast, the addition of 3.75ig of CBGF/ml of low-serum medium led to rapid cell proliferation with a minimal population doubling time of approx. 24h (Fig.  5 ). An attempt was made to grow 3T3 cells in DME with added CBGF in the complete absence of calf serum supplement. Initially the cells attached to the plastic dish, but by 24h after seeding all of the cells had rounded and detached. After 10 days, the cultures in unsupplemented, serum-free DME remained isolated, unattached, and appeared nonviable (Fig. 6a) . In contrast, the cells in serum-free medium supplemented with unfractionated colostric whey (Fig. 6b) or with the post-AcA 54 pool of CBGF (Fig. 6c) had formed floating cell colonies. The colonies ranged in size from a few cells to several hundred cells with the largest colonies in the dishes supplemented with unfractionated colostric whey. These colonies were composed of viable cells (not aggregates of dead cells) since, on adding calf serum to the cultures, the colonies attached to the substratum and cells migrated from the colonies (Figs. 6e and 6f ). In contrast, isolated unattached cells present in unsupplemented medium failed to attach when calf serum was added (Fig.  6d ).
Discussion
We have characterized a major growth factor (colostric basic growth factor, CBGF) in the colostrum of goats and have demonstrated that it is a basic polypeptide with Mr approx. 35000 which inhibits the cellular binding of 125I-EGF. CBGF differs chemically from either mouse or human EGF, which are acid polypeptides of Mr 6000. Our results indicate that CBGF is indeed much more closely related to the growth factor isolated from human platelets, PDGF (Heldin et al., 1981a; Deuel et al., 1981; Raines & Ross, 1982) . Firstly, CBGF and PDGF are highly basic proteins with very similar Mr. Furthermore, CBGF (Table 2) and PDGF (see Ross, 1981 ) exhibit a similar resistance to denaturation by heat, urea and guanidinium chloride, while both are completely inactivated by exposure to reducing agents. In addition, the factors display a functional similarity in acting as 'competence' factors (Pledger et al., 1977 (Pledger et al., , 1978 Vogel et al., 1978) synergistically interacting with platelet-poor plasma to stimulate cell proliferation. Finally, we have recently found ) that human PDGF inhibits 125I-EGF binding to Swiss 3T3 cells by an indirect, temperature-sensitive mechanism similar to that found for the inhibition of 125I-EGF binding by colostrum (Brown & Blakeley, 1983b Huang et al., 1982) .
Human PDGF is present in platelet a-granules (Kaplan et al., 1979) and is probably synthesized in megakaryocytes in conjunction with a-granule formation (Chernoff et al., 1980) . The origin of CBGF is unknown but the close similarity with PDGF raises the possibility that the colostric factor is derived from goat platelets. A recent phylogenetic analysis of PDGF by radioreceptor assay (Singh et al., 1982) showed that sera from all mammals tested contained PDGF activity. Furthermore, we have found (results not shown) that release-products from freshly prepared goat platelets contain a potent, cationic mitogen for 3T3 cells. It is possible, therefore, that CBGF accumulates in colostrum as a consequence of platelet degranulation. However, it has recently been shown that another a-granule protein, thrombospondin, is not platelet-specific since it is synthesized and secreted by cultured endothelial cells (Mosher et al., 1982) and by cultured fibroblasts (Jaffe et al., 1983) . Furthermore, PDGF-like polypeptides are produced by some transformed cells in culture (Heldin et al., 1980; Dicker et al., 1981) . These results raise the possibility that CBGF may be derived from a non-platelet source, perhaps in the mammary gland itself.
Steimer & Klagsbrun (1981) have reported that bovine colostrum is deficient in cell attachment factors when compared with bovine serum. Untransformed fibroblastic cell lines failed to attach to the substratum in serum-free medium supplemented with bovine colostrum, although precoating the culture dishes with fibronectin allowed cell attachment and subsequent proliferation. Colstrum-supplemented serum-free medium supported the anchorage-independent growth of colonies of virus-transformed fibroblasts, but untransformed cell lines did not show a similar response. The Swiss 3T3 cells used in the present work are an untransformed cell line in that they have a high serum requirement for proliferation and a low saturation density (approx. 5 x 104cells/cm2) in medium supplemented with 10% calf serum. In addition, the cells do not form colonies in agarose culture in medium supplemented with 10% calf serum. Nevertheless, we have observed that goat colostrum (Fig. 6b) is able to promote the anchorage-independent formation of colonies of these cells. Furthermore, this effect is mediated, at least in part, by CBGF, which also promoted the formation of viable, floating cell colonies (Fig. 6c) Qualitative as well as quantitative differences exist between the growth factor content of mammary secretions from different species. The concentration of EGF (measured by homologous radioimmunoassay) in mouse milk has been reported to increase from birth to reach a maximal concentration of approx. 430ng/ml at day 8 of lactation. These high EGF concentrations were maintained until day 17 and the approach of weaning (Beardmore & Richards, 1983) . Human milk (donated 5 weeks post-partum) was shown to be highly active in stimulating DNA synthesis in quiescent human fibroblasts, and approx. 70% of this activity was blocked by antibodies to human EGF (Carpenter, 1980) . These results indicate that EGF is the major cell growth factor of human (and probably mouse) mammary secretions and high levels of the factor are found in mature milk obtained in mid-lactation. In contrast, the mammary secretions of the domestic ruminants show a very different pattern of cell growth-promoting activity, with high activity in pre-colostrum and colostrum falling to very low levels within the first few days after parturition (Brown & Blakeley, 1983a,b The physiological function of cell growth factors in mammary secretions is unknown. It has been postulated (Brown & Blakeley, 1983b ) that these factors may play a role in the growth and development of the mammary gland of the mother and/or the control of cell proliferation in the intestinal epithelium ofthe neonate. Since EGF has been shown to stimulate the proliferation of mammary (Imagawa et al., 1982) and intestinal (Blay & Brown, 1983) epithelial cells in vitro it is possible that EGF in mouse and human milk might act at these sites in vivo. In contrast, PDGF is active only on connective tissue-derived cells and not on epithelial cells, which appear to lack PDGF receptors (Heldin et al., 198 lb) . The close biochemical similarity of CBGF with PDGF suggests that this factor will also fail to stimulate epithelial cells and preliminary experiments (results not shown) support this hypothesis. Thus, any effect of the colostric factor on the growth of mammary or intestinal epithelium would have to occur indirectly via an effect on stromal cells. However, a stimulation of the growth of epithelial cells by unfractionated bovine colostrum has been reported (Klagsbrun, 1980) . It is possible that the uncharacterized growth factors, distinct from CBGF and shown to be present in the unfractionated colostrum (Fig. 1) , produce this effect.
